Castle Biosciences Announces Full Exercise of Underwriters` Option to Purchase Additional Shares of Common Stock
(WorldNews Business)

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Jul 2, 2020-- Castle Biosciences, Inc. (Nasdaq: CSTL), announced today that the underwriters of its recently closed underwritten public offering of 2,000,000 shares of its common stock have exercised in full their option to purchase an additional 300,000 shares of common stock at the public offering price of $37.00 per share, less underwriting discounts and commissions. The gross proceeds to...